AU Patent

AU2017312712B2 — Beta-amino-isoquinolinyl amide compounds

Assigned to Alcon Inc · Expires 2019-12-12 · 6y expired

What this patent protects

Disclosed are

USPTO Abstract

Disclosed are

Drugs covered by this patent

Xalatan (LATANOPROST) · Thea Pharma

Patent Metadata

Patent number: AU2017312712B2
Jurisdiction: AU
Classification: —
Expires: 2019-12-12
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.